Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1982 Dec;38(3):921–924. doi: 10.1128/iai.38.3.921-924.1982

Synergistic effect of Candida albicans and Staphylococcus aureus on mouse mortality.

E Carlson
PMCID: PMC347837  PMID: 7152678

Abstract

A synergistic effect on mouse mortality was demonstrated in combined infection of mice with Candida albicans and a Staphylococcus aureus strain isolated from a patient with toxic shock syndrome. Mice exhibited high resistance when inoculated intraperitoneally by either pathogen alone. Dual infection with the two organisms together, however, at doses which separately caused no animal deaths, resulted in 100% mortality. This synergistic effect could not be reproduced when either of the agents was heat inactivated.

Full text

PDF
921

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BENNETT B. M. Estimation of LD50 by moving averages. J Hyg (Lond) 1952 Jun;50(2):157–164. doi: 10.1017/s0022172400019513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Castells S., Inamdar S., Orti E. Familial moniliasis, defective delayed hypersensitivity, and adrenocorticotropic hormone deficiency. J Pediatr. 1971 Jul;79(1):72–79. doi: 10.1016/s0022-3476(71)80061-6. [DOI] [PubMed] [Google Scholar]
  3. Conway H. Emergency medical care. Br Med J. 1976 Aug 28;2(6034):511–513. doi: 10.1136/bmj.2.6034.511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Davis J. P., Chesney P. J., Wand P. J., LaVenture M. Toxic-shock syndrome: epidemiologic features, recurrence, risk factors, and prevention. N Engl J Med. 1980 Dec 18;303(25):1429–1435. doi: 10.1056/NEJM198012183032501. [DOI] [PubMed] [Google Scholar]
  5. Drake T. E., Maibach H. I. Candida and candidiasis. 1. Cultural conditions, epidemiology and pathogenesis. Postgrad Med. 1973 Feb;53(2):83–87. doi: 10.1080/00325481.1973.11713368. [DOI] [PubMed] [Google Scholar]
  6. Durack D. T. Opportunistic infections and Kaposi's sarcoma in homosexual men. N Engl J Med. 1981 Dec 10;305(24):1465–1467. doi: 10.1056/NEJM198112103052408. [DOI] [PubMed] [Google Scholar]
  7. Gottlieb M. S., Schroff R., Schanker H. M., Weisman J. D., Fan P. T., Wolf R. A., Saxon A. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med. 1981 Dec 10;305(24):1425–1431. doi: 10.1056/NEJM198112103052401. [DOI] [PubMed] [Google Scholar]
  8. Hamilton J. R., Overall J. C., Glasgow L. A. Synergistic effect on mortality in mice with murine cytomegalovirus and Pseudomonas aeruginosa, Staphylococcus aureus, or Candida albicans infections. Infect Immun. 1976 Oct;14(4):982–989. doi: 10.1128/iai.14.4.982-989.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hurley R. Inveterate vaginal thrush. Practitioner. 1975 Dec;215(1290):753–756. [PubMed] [Google Scholar]
  10. KEENEY E. L. Candida asthma. Ann Intern Med. 1951 Jan;34(1):223–226. doi: 10.7326/0003-4819-34-1-223. [DOI] [PubMed] [Google Scholar]
  11. LOURIA D. B., FALLON N., BROWNE H. G. The influence of cortisone on experimental fungus infections in mice. J Clin Invest. 1960 Sep;39:1435–1449. doi: 10.1172/JCI104163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Lapan B. Is the "pill" a cause of vaginal candidiasis? Culture study. N Y State J Med. 1970 Apr 15;70(8):949–951. [PubMed] [Google Scholar]
  13. NEUFELD O., WALLBANK W. L. Case of candida asthma and its management. J Mich State Med Soc. 1952 Nov;51(11):1419–1420. [PubMed] [Google Scholar]
  14. ROTH F. J., Jr, FRIEDMAN J., SYVERTON J. T. Effects of roentgen radiation and cortisone on susceptibility of mice to Candida albicans. J Immunol. 1957 Feb;78(2):122–127. [PubMed] [Google Scholar]
  15. Rogers T. J., Balish E. Immunity to Candida albicans. Microbiol Rev. 1980 Dec;44(4):660–682. doi: 10.1128/mr.44.4.660-682.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Russell C., Jones J. H. Effects of oral inoculation of Candida albicans in tetracycline-treated rats. J Med Microbiol. 1973 Aug;6(3):275–279. doi: 10.1099/00222615-6-3-275. [DOI] [PubMed] [Google Scholar]
  17. SONCK C. E., SOMERSALO O. THE YEAST FLORA OF THE ANOGENITAL REGION IN DIABETIC GIRLS. Arch Dermatol. 1963 Dec;88:846–852. doi: 10.1001/archderm.1963.01590240170029. [DOI] [PubMed] [Google Scholar]
  18. Schlievert P. M., Osterholm M. T., Kelly J. A., Nishimura R. D. Toxin and enzyme characterization of Staphylococcus aureus isolates from patients with and without toxic shock syndrome. Ann Intern Med. 1982 Jun;96(6 Pt 2):937–940. doi: 10.7326/0003-4819-96-6-937. [DOI] [PubMed] [Google Scholar]
  19. Shannon D. C., Johnson G., Rosen F. S., Austen K. F. Cellular reactivity to Candida albicans antigen. N Engl J Med. 1966 Sep 29;275(13):690–693. doi: 10.1056/NEJM196609292751302. [DOI] [PubMed] [Google Scholar]
  20. Todd J., Fishaut M., Kapral F., Welch T. Toxic-shock syndrome associated with phage-group-I Staphylococci. Lancet. 1978 Nov 25;2(8100):1116–1118. doi: 10.1016/s0140-6736(78)92274-2. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES